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Abstract
The putative virulence and antimicrobial resistance gene contents of extended spectrum β-lactamase (ESBL)-
positive E. coli (n=629) isolated between 2005 and 2009 from humans, animals and animal food products in
Germany, The Netherlands and the UK were compared using a microarray approach to test the suitability of this
approach with regard to determining their similarities. A selection of isolates (n=313) were also analysed by
multilocus sequence typing (MLST). Isolates harbouring blaCTX-M-group-1 dominated (66%, n=418) and originated from
both animals and cases of human infections in all three countries; 23% (n=144) of all isolates contained both blaCTX-M-
group-1 and blaOXA-1-like genes, predominantly from humans (n=127) and UK cattle (n=15). The antimicrobial resistance
and virulence gene profiles of this collection of isolates were highly diverse. A substantial number of human isolates
(32%, n=87) did not share more than 40% similarity (based on the Jaccard coefficient) with animal isolates. A further
43% of human isolates from the three countries (n=117) were at least 40% similar to each other and to five isolates
from UK cattle and one each from Dutch chicken meat and a German dog; the members of this group usually
harboured genes such as mph(A), mrx, aac(6’)-Ib, catB3, blaOXA-1-like and blaCTX-M-group-1. forty-four per cent of the MLST-
typed isolates in this group belonged to ST131 (n=18) and 22% to ST405 (n=9), all from humans. Among animal
isolates subjected to MLST (n=258), only 1.2% (n=3) were more than 70% similar to human isolates in gene profiles
and shared the same MLST clonal complex with the corresponding human isolates. The results suggest that
minimising human-to-human transmission is essential to control the spread of ESBL-positive E. coli in humans.
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Introduction
Escherichia coli is a commensal organism in people and
animals but is also a causative agent of diarrhoea and extra-
intestinal infections. It is responsible for an estimated 120
million cases of community-acquired urinary tract infections
(UTI) diagnosed worldwide annually. It can also cause neonatal
meningitis, pneumonia and surgical site infections. The sepsis-
associated mortalities due to E. coli are estimated at 868,000
per year globally [1]. In England, Wales and Northern Ireland,
E. coli has been the most common cause of bacteraemia for
most years since 1990, with year-on-year increases to 27,055
reports in 2010 [2].
Since circa 2003, there has been a rapid and global increase
in the occurrence of E. coli with resistance to oxyimino-
cephalosporins due to the production of extended-spectrum β-
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lactamases (ESBLs). These isolates have emerged in both
community and healthcare settings, are often also resistant to
other antimicrobial agents, including fluoroquinolones,
aminoglycosides and sulphonamides and resistant isolates
have been associated with treatment failures [3]. Bacteraemia
caused by ESBL producers can be associated with increased
mortality, primarily because multi-resistance undermines the
efficacy of empiric therapies, which are prescribed before the
antimicrobial susceptibility of the infecting organism is known
[4]. The CTX-M types of β-lactamases are the dominant family
of ESBLs in E. coli, with particular subtypes associated with
different geographic regions. However, the CTX-M-15 ESBL is
pandemic and is often disseminated with the O25:H4-ST131 E.
coli clone [5-7].
The occurrence of ESBL-positive E. coli in animals is also
showing a general tendency to increase in some countries,
among those bacteria isolated from the poultry gut as well as
among those that contaminate food products [8-13]. The rise of
community-acquired urinary tract infections caused by E. coli
resistant to 3rd - or 4th - generation cephalosporins has been
linked to international travel of people to countries of high
prevalence [13-17] and to reservoirs of resistant bacteria in
food-producing animals, especially poultry [13,18]. To explore
the genetic relatedness of ESBL- and/or plasmid-mediated (p)
AmpC-β-lactamase-producing E. coli, we used virulence and
resistance gene microarrays as a convenient and rapid tool to
investigate isolates from Germany, The Netherlands and the
UK obtained from humans, food producing animals and animal
food products. A subset of these isolates was also
characterised by multi-locus sequence typing (MLST) to assist
in elucidating the clonal relationship of isolates.
Materials and Methods
Sources of isolates
This study sought to compare ESBL/pAmpC-producing E.
coli from the animal gut flora, animal-derived food products and
from cases of human infections, especially from urinary tract
infections (UTI) where the ESBL-producing isolates were often
identified. For this, E. coli isolates that showed resistance to
both ampicillin and cefotaxime, based on EUCAST criteria
(www.eucast.org), and that had been isolated between 2005
and 2009 were included in this study. The isolates were from
existing strain collections of the UK (AHVLA and Public Health
England, formerly the Health Protection Agency), Germany
(FLI and BfR) and The Netherlands (CVI) and had been
obtained as part of national antimicrobial resistance
surveillance programmes or from participants’ routine
diagnostic or reference laboratory activities. The UK poultry
isolates were from a structured survey [19] and those from
cattle were derived from scanning surveillance of clinical
diagnostic submissions to the 14 AHVLA regional laboratories
across England and Wales [20]. The German isolates were
from the collection at the National Reference Laboratory for E.
coli (NRL-E. coli) and the NRL for Antimicrobial Resistance
(NRL-AR) of the BfR (for food and animal isolates) and the
National Reference Centre for Salmonella and other enterics
(NRZ, human isolates, Robert Koch Institute). In addition, all
putative ESBL-producing E. coli isolates from the BfT-GermVet
collection were included [21]. The Dutch human isolates were
selected from a national ESBL-prevalence study conducted in
Public Health Laboratory Services in 2009 [13] and the animal
isolates were selected from the collection of the NRL-AR (CVI).
No field samples were specifically collected for this study. E.
coli isolates (n= 629) from animals (n=295), animal-derived
foods (n=59), humans (n=274) and an unknown source (n=1),
originating from Germany (n=84), The Netherlands (n =254)
and the UK (n =291) were analysed using microarrays (Table
1). MLST analysis was performed on 313 isolates isolated from
different countries and host species.
Microarray analysis
The principle and methodology of the microarray have been
described previously [22-24] and the probe content was
described by Geue et al. [25] and can be found at: http://alere-
technologies.com/fileadmin/Media/Paper/Ecoli/
Supplement_Geue__layout_E_coli.xlsx. In addition, a
description of the probes that generated positive signals among
isolates can be found in Table S1. The blaCTX-M family probes
identified genes only to group level (i.e. groups 1, 2, 8/25, 9)
[26], and the blaSHV and blaTEM probes did not identify their
precise alleles. The virulence probes allowed the detection of
major pathotypes of E. coli such as enteropathogenic E. coli
(EPEC), verotoxigenic E. coli (VTEC), enterotoxigenic (ETEC),
extra-intestinal pathogenic E. coli (ExPEC) from humans and
animals including avian pathogenic E. coli (APEC), and
uropathogenic E. coli (UPEC) as described previously [23]. All
probes were present on the array in duplicate, except probes
for sul3, tet(A-G), blaTEM, which were singletons.
Hybridisation signals were normalised to the 50th percentile
of the signal intensities of control genes: ihfA, gad, gapA, hemL
and dnaE. Normalised signal intensities with values >0.1 were
in 95% in agreement with positive PCR results for blaCTX-M-group-1
(n=248) and blaCTX-M-group-9 (n=95) and 100% agreement with
four blaCTX-M-group-2, blaTEM (n=11) and blaSHV (n=5) [27]; a gene
was therefore considered present if the complementary array
probe(s) produced normalised signal intensity that was >0.1.
Cluster analysis of isolates was performed with Jaccard
coefficients and Unweighted Pair Group Method with Arithmetic
Mean (UPGMA, Bionumerics 5.1, Gent, Belgium). Isolates
were grouped where stated to form larger clusters at different
similarity levels; when the similarity level is not indicated, a
40% similarity threshold was used.
Analysis of the diversity of isolates
To assess the diversity of isolates from each country and
host species, different similarity cut-off points were used to
group isolates into larger clusters to facilitate their comparison.
The number of isolates within each cluster from each host
species and country was counted and the Simpson’s Index of
Diversity (1 -D) was calculated [28]. The distribution of isolates
from each country and species among those clusters was
analysed. Where possible, genes specifically associated with,
and hence potentially indicative of major clusters, were
identified.
ESBL-Producing E. coli from Three Countries
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E. coli MLST typing
In order to estimate the relative importance of clonal spread
versus horizontal gene transfer in the dissemination of ESBL
genes, and to assess the association between virulence and
resistance genes with genetic backbones of the host bacteria,
isolates (n=313) representing different countries of origin or
different host species were analysed by MLST according to the
scheme described by Wirth et al. [29] following the guidelines
given at http://mlst.ucc.ie/mlst/dbs/Ecoli
Results
Pathotypes of E. coli isolates and the presence of
major ESBL/ pAmpC β-lactamase genes.
Virulence genes and antimicrobial resistance genes
identified by microarrays are listed in Table S1. Only 0.5% of
isolates (n=3) were ETEC and harboured the fim41 (encoding
F41 fimbria) and sta1 (encoding a heat-stable toxin) genes
[30]. Fewer than 7.5% of the isolates (n=46) were EPEC (that
contained eae encoding intimin) or VTEC, harbouring both eae
and stx genes (the latter gene encoding Shiga toxins).
The majority of isolates were either commensal or ExPEC
and typically harbouring prfB (encoding P-related fimbria,
n=241, 38% of the isolates) and/or iroN (encoding the
enterobactin siderophore receptor protein) or microcin genes;
13% of isolates (n=80) contained tsh (encoding a temperature-
sensitive haemagglutinin), a gene often associated with APEC
[31]. Hybrid pathotypes of ExPEC and EPEC were also
identified: three isolates (0.5%) harboured both prfB and eae.
In addition, about 20% of Dutch chicken isolates (n=28)
harboured EPEC-associated genes [30] and nearly half (n=13)
also carried tsh (Table S1).
As expected, blaCTX-M-group-1 predominated amongst the CTX-
M genes and was detected in 418 of 629 (66%) isolates (Table
1). Additionally, blaOXA-1-like genes were found in combination
with blaCTX-M-group-1 genes in about 23% of the isolates (n=144),
mainly from humans (88%, n=127) and UK cattle (10%, n=15),
but also in single isolates from Dutch chicken meat (ESBL428)
and from a German pig (ESBL 154). While blaCTX-M-group-1 genes
were widespread in all host species and in all three countries,
blaCTX-M-group-9 genes were more common among cattle and
turkey isolates from the UK (Table 1). Forty isolates were
positive for blaSHV, among which 6 and 25 were from Dutch and
UK humans respectively, one and 8 from Dutch cattle and
chickens respectively. More than half of the isolates (n=399)
were blaTEM positive, which were from all species and countries
studied here. However, the array does not distinguish the
ESBL and non-ESBL forms of blaSHV and blaTEM genes.
Table 1. Distribution of selected β-lactamase genes in E. coli from different hosts1 and countries.
Host Country Percentage (no. of positive isolates)
  Isolates (n) blaCTX-M-group-1 blaCTX-M-group-9 blaSHV blaCMY-6112 blaCMY_113 bla MOX-cmy_94
 All 274 74% (204) 8% (23) 11% (31) 0.7% (2) 3% (8) 7% (18)
 UK 152 74% (112) 6% (9) 16% (25) 0 5% (7) 10% (15)
Human Germany 14 93% (13) 7% (1) 0 7% (1) 7% (1) 7% (1)
 Netherlands 108 73% (79) 12% (13) 6% (6) 1% (1) 0 2% (2)
 All 157 55% (86) 1% (1) 5% (8) 22% (35) 22% (34) 3% (5)
 UK 10 100%(10) 0 0 0 0 0
Chicken Germany 11 18% (2) 0 0 72% (8) 73% (8) 0
 Netherlands 136 54% (74) 1% (1) 6% (8) 20% (27) 19% (26) 4% (5)
 All 133 63% (84) 31% (41) 1% (1) 3% (4) 2% (3) 1% (1)
 UK 95 57% (54) 43% (41) 0 2% (2) 2% (2) 0
Cattle Germany 32 81% (26) 0 0 0 0 3% (1)
 Netherlands 6 67% (4) 0 17% (1) 33% (2) 17% (1) 0
 All 35 63% (22) 46% (16)    3% (1)
Turkey UK 32 63% (20) 50% (16) 0 0 0 3% (1)
 Germany 2 50% (1) 0 0 0 0 0
 Netherlands 1 100% (1) 0 0 0 0 0
 All 17 94% (16)      
 UK 1 100% (1) 0 0 0 0 0
Pig Germany 13 92% (12) 0 0 0 0 0
 Netherlands 3 100% (3) 0 0 0 0 0
All5  629 66% (418) 13% (81) 6% (40) 7% (44) 7% (48) 4% (25)
1 The precise sources of strains can be found in Table S1. Those from meat products were counted as if they were from the corresponding animals.
2 blaCMY-611, probe name and the sequence was found in blaCMY-2 (AB212086.1[93:118])and blaCMY-13 (AY339625.2[4669:4694:r])
3 blaCMY_11, probe name and the sequence was found in blaCMY-2 (AB212086.1[569:592])and blaCMY-13 (AY339625.2[4195:4218:r]
4 bla MOX-cmy_9, probe name and the sequence was in bla MOX-cmy_9 (AF357599.1[379:402])
5 There were also 6 isolates labelled as from poultry and 4 from cats/dogs from Germany, one UK isolate from sheep and 2 from unknown German animals.
doi: 10.1371/journal.pone.0075392.t001
ESBL-Producing E. coli from Three Countries
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Analysis of the diversity among the isolates
Isolates were clustered initially using the Jaccard coefficient
and UPGMA (Bionumerics 5.1) based on the presence or
absence of virulence and antimicrobial resistance genes. To
identify isolates that may be related, similar isolates were
grouped together into larger clusters. Isolates were divided into
12 clusters at 15% similarity and four of those clusters
contained a single isolate, but approximately 76% of the 629
isolates were grouped in a single cluster (not shown). At 25%
similarity, isolates were divided into 33 clusters of which 9
contained a single isolate, but 24%, 17% and 26% of the
isolates were in three clusters respectively (data not shown). At
40% similarity, isolates were divided into 114 clusters (Figure
1). When raising the similarity threshold, the number of defined
clusters increased further so that at 90% similarity, isolates
were separated into 556 clusters, with 484 (87%) of them being
singletons and only 8 clusters including isolates from different
species.
To calculate the diversity of isolates, a series of cut-off points
from 25% to 90% were used and the number of isolates from
each category (country and species) in each cluster was
counted and used to calculate the index of diversity and to plot
the results (Figure 2). This approach showed that isolates from
The Netherlands and Germany were very diverse and the
differences were most pronounced between the 25% and 50%
similarity levels. Only 14 human isolates from Germany were
included; their high diversity was probably due to the inclusion
of EPECs, whereas the human isolates from The Netherlands
and the UK originated exclusively from urinary tract infections.
With the exception of turkey isolates, the UK isolates showed
the lowest overall diversity (Figure 2). As only three turkey
isolates from Germany and The Netherlands were included in
Figure 1.  Isolates were grouped into 114 clusters at the 40% similarity level.  
doi: 10.1371/journal.pone.0075392.g001
ESBL-Producing E. coli from Three Countries
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this study, a valid comparison with those from the UK could not
be made.
Comparison of isolates from different host species and
countries
While microarrays detect virulence and antimicrobial
resistance genes that are often acquired through horizontal
gene transfer, MLST provides information on the genetic
backbone of host strains. In this study, MLST analysis was
performed on 313 isolates in order to seek relationships
between array clustering and multilocus sequence types (ST,
Figure 3). The results showed that the major array clusters
(e.g. 27, 30, 34, 42, 49, 50, 76, 103) all contained isolates of
numerous STs, and that isolates of major STs (ST131 n=45,
ST10 n=25, ST88 n=24, ST405 n=11, ST69 n=10, ST58 n=10)
were divided among several very different array clusters
(Figure 3). The largest array cluster, 76, consisted of 124
isolates of which 41 were typed by MLST [humans (n=36), UK
cattle (n=3), Dutch chicken meat (n=1) and German dog (n=1)].
Among them, 44% (n=18, all from humans) belonged to ST131,
22% (n=9, all from humans) to ST405, 12% (n=5) to the ST10
complex and 5% (n=2) to the ST23 complex. Conversely, of 44
ST131 isolates only 43% were grouped in cluster 76. In the
following sections, isolates from each host species were
analysed together.
At the 40% similarity level, human isolates (n=274) were
scattered among 69 clusters, but 43% (n=117) were in cluster
76 (Figure 1), including those from the UK (82/152), The
Netherlands (33/108) and Germany (2/14). The isolates in this
cluster were defined as the “common human type” and usually
contained genes mph(A), encoding a macrolide 2’-
phosphotransferase; mrx, encoding a putative protein; aac(6’)-
Ib, encoding an aminoglycoside 6'-N-acetyltransferase; catB3,
encoding a chloramphenicol acetyltransferase as well as the
blaOXA-1-like and blaCTX-M-group-1 β-lactamase genes. A small
number of the human isolates from the UK (13%, n=20) and
The Netherlands (1.9%, n=2) were grouped in clusters 94 to
100 which harboured less commonly detected resistance
genes such as blaSHV and/or blaCTX-M-group-2. In addition, 33.6% of
isolates from cases of human infection in the Netherlands were
in clusters 29-34, 36, 37, 39, 42 and 44 (Figure 1). All in all, a
total of 32% (n=87) of human isolates were in 40/69 clusters,
which consisted of only human isolates, and a further 43% in
cluster 76 in which 95% were human isolates. On the other
hand, 19 human isolates (7% of the total human isolates) were
at least 70%, 13 human isolates (4.7%) were at least 80%, and
five human isolates (1.8%) were at least 90% similar to animal
isolates in array profiles based on the Jaccard coefficient.
Chicken isolates (n=157) were found among 40 clusters at
the 40% similarity level; 20% of the total were in 13 of these
clusters, which consisted only of chicken isolates. Dutch
chicken isolates harbouring blaCTX-M-group-1 often also carried intI1
(integrase gene of class 1 integron), while those from the UK
often carried intI2 (integrase gene of class 2 integron). The
Dutch chicken meat isolate ESBL428 (ST88) found in cluster
76 shared the ST23 clonal complex (which is the second
largest clonal complex within the E. coli MLST database) with a
Dutch human isolate ESBL7 (ST 90), however, the similarity in
array profiles between these two isolates was just over 40%. In
addition, 21% (n=29) of Dutch chicken isolates shared 13 array
clusters with human isolates. Also, 19% (n=26) of Dutch
chicken isolates were in cluster 103 together with one German
and two Dutch cattle isolates (Figure 1). The isolates in this
cluster harboured genes often found among EPEC, such as
eae and genes encoding type III secretion system, and half of
those isolates also carried tsh.
Figure 2.  Simpson’s Index of Diversity (1-D) of isolates from different categories (country and host species) at the
similarity levels from 25% to 90%.  
doi: 10.1371/journal.pone.0075392.g002
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Cattle isolates (n=133) were found among 41 clusters at the
40% similarity level and 23% (n=31) of the isolates were in
16/41 clusters that consisted of only cattle isolates. About 61%
(n=81) of cattle isolates (from all three countries) shared
clusters with less common human types (mostly Dutch) and 5%
(n=5) of the cattle isolates from the UK were found in cluster
76. Two of the isolates in this cluster (ESBL569, ST167 and
ESBL528, ST1284, both were within the ST10 clonal complex,
the largest clonal complex within the E. coli MLST database)
were at least 70% or 80% similar in array profiles to human
isolates (ESBL73, ST617 from The Netherlands; ESBL760,
ST167 and ESBL691, a double locus variant of ST1284, both
were from the UK) that also belonged to this ST clonal
complex. The UK cattle isolate ESBL528 shared more than
90% similarity in array profiles with the Dutch human isolate
ESBL106. In array cluster 30, ESBL517 from UK cattle and
ESBL101 from a Dutch human patient were both ST58 and
were at least 80% similar in their array profiles. In terms of the
differences in genes they harboured, blaCTX-M-group-9 was found in
cattle isolates from the UK, but not in those from The
Netherlands or Germany (Table 1). Among the six cattle
isolates from The Netherlands, diverse genes including ESBL/
AmpC genes blaCMY, blaSHV, and virulence genes f17A, f17G
and cif, were detected. Cattle isolates from Germany (in cluster
42) harboured different genes as compared to cattle isolates
from the UK (Figure 1).
Turkey isolates (n=35) were found in 16 clusters and 25.7%
(n=9) of them were in five clusters which consisted of only
turkey isolates, while 54% (from UK, n=17; Germany, n=1 and
The Netherlands, n=1) of those shared clusters with human
Figure 3.  Minimal spanning tree constructed based on the MLST profiles of the 313 isolates (Bionumerics V6) and
coloured according to the cluster numbers: red, cluster 76; purple, cluster 103; light blue, cluster 30; dark green, cluster
42; green, no array data and white, a mixture of rare cluster number.  
doi: 10.1371/journal.pone.0075392.g003
ESBL-Producing E. coli from Three Countries
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isolates from The Netherlands and the UK. All these turkey
isolates were different from the “common human type”. Six
turkey isolates were more than 70% similar and four were more
than 80% similar to human isolates. One UK turkey isolate
(ESBL 626) was 90% similar to the Dutch human isolate ESBL
80.
The 17 pig isolates, 13 of which were from Germany, were
found in seven clusters. No cluster was observed that
contained only pig isolates. All but one pig isolate (94%)
clustered with human isolates. The majority (71%, n=12)
harboured genes mph(A) and mrx; both genes were typically
found among the “common human type”. Two pig isolates
shared more than 70% similarity with human isolates, but their
MLST profiles (single locus variant of ST348) were dissimilar to
the respective human isolates ESBL116 (ST453) and ESBL80
(a double locus variant of ST167).
Genes that were unevenly distributed among different
host species and countries
Genes found significantly more or less common among
isolates from humans and cattle in comparison with other
species are summarized in Table 2. Antimicrobial resistance
genes blaOXA-1-like, aac(6’)-Ib, catB3 and virulence genes iha
(encoding an adhesion), sat (encoding serine protease
precursor), prfB were frequently found among human isolates,
especially among the UK human isolates from urinary tract
infections (Table S2). The long polar fimbria gene (lpfA) was
less commonly represented among human isolates, especially
among those from the UK (3.3%) as compared with those from
The Netherlands (14.8%). The gene floR, which confers
resistance to florfenicol, was seen among 33% of the cattle
isolates, but was rare among isolates of other species (Table
2). Florfenicol is a fluorinated derivative of chloramphenicol
approved for use in cattle in Europe since 1995 [32]. The espP
gene that encodes serine protease autotransporter and mcmA
that encodes for microcin M protein were significantly more
common among cattle isolates than other species (Table 2).
Genes that were more or less common in E. coli isolates from
each country are listed in Tables S2 and S3.
Discussion
In this study, we assessed the use a microarray approach to
study gene relatedness among ESBL carrying E. coli. Many of
the genes represented on the array are readily transmissible
being encoded on mobile genetic elements. Therefore, we
might anticipate greater diversity using this approach than
other standard methods such as PFGE and MLST that focus
on the genetic backbone of a strain. One advantage of the
array approach that in this study detected genes encoding
important phenotypes, in this case resistance and virulence, is
the ability to identify known and novel (potentially emerging)
gene associations.
A considerable number of human E. coli isolates (32%) did
not share array clusters with animal isolates and a further 43%
were concentrated in one cluster (cluster 76), which consisted
mainly of human isolates. These results are consistent with a
recent observation that the blaCTX-M-carrying E. coli isolates
from UK chicken and turkey were different from the human-
associated ST131 CTX-M-15 type in the UK [19]. In another
study, 11% of human isolates were found to contain poultry-
associated ESBL genes, plasmids and MLST types in The
Netherlands [13], however, this study did not investigate
virulence and additional antimicrobial resistance genes. In this
study, only 1.2% (3/258) of characterized E. coli from animals
were similar (as judged by gene content and clonal complex) to
isolates from humans.
Nearly half of the human isolates investigated in this study
were located in clusters surrounding cluster 76 and many of
those belonged to ST131. Therefore, those isolates are likely to
be similar to E. coli ST131-O25:H4-B2 that harboured blaCTX-
M-15 plasmids (as blaCTX-M-15 belongs to blaCTX-M-group-1) [33,34].
Moreover, ST131 was found among 11 different array clusters,
which is consistent with the reports that O25:H4-B2- ST131
Table 2. Genes that show significant differential presence among isolates from different species.
Genes The proportion of isolates where the gene is present (The binomial 95% exact confidence interval)
More common among human Isolates Human Chicken Pig Turkey Cattle
aac6 0.482 (0.42,0.54) 0.006 (0,0.03) 0 (0,0.19) 0.057 (0,0.19) 0.075 (0.03,0.13)
aac(6’)-Ib 0.507 (0.44,0.56) 0.006 (0,0.03) 0 (0,0.19) 0.086 (0.01,0.23) 0.083 (0.04,0.14)
blaOXA-1-like 0.485 (0.42,0.54) 0.006 (0,0.03) 0.059 (0,0.28) 0 (0,0.1) 0.165 (0.1,0.24)
catB3 0.456 (0.39,0.51) 0.006 (0,0.03) 0 (0,0.19) 0 (0,0.1) 0.06 (0.02,0.11)
iha 0.504 (0.44,0.56) 0.019 (0,0.05) 0 (0,0.19) 0.086 (0.02,0.23) 0.211 (0.14,0.29)
sat 0.482 (0.42,0.54) 0 (0,0.02) 0 (0,0.19) 0.057 (0,0.19) 0.008 (0,0.04)
prfB 0.613 (0.55,0.67) 0.076 (0.04.0.13) 0.176 (0.03,0.43) 0.029 (0,0.14) 0.421 (0.33,0.51)
Less common among human Isolates      
lpfA 0.084 (0.05,0.12) 0.268 (0.2,0.34) 0.353 (0.14,0.61) 0.286 (0.14,0.46) 0.256 (0.18,0.33)
More common among bovine Isolates      
floR 0.026 (0.01,0.05) 0.057 (0.02,0.1) 0 (0,0.19) 0 (0,0.1) 0.331 (0.25,0.41)
espP 0.011 (0,0.03) 0.013 (0,0.04) 0.059 (0,0.28) 0.029 (0,0.14) 0.489 (0.4,0.57)
mcmA 0.113 (0.07,0.15) 0.019 (0,0.05) 0.059 (0,0.28) 0.057 (0,0.19) 0.444 (0.35,0.53)
doi: 10.1371/journal.pone.0075392.t002
ESBL-Producing E. coli from Three Countries
PLOS ONE | www.plosone.org 7 September 2013 | Volume 8 | Issue 9 | e75392
isolates carry various blaCTX-M types on a number of different
plasmid types (Inc FII, FIA-FIB, FIA, FII-FIA, I1, N and Y for
example) [35,36]. The O25:H4-ST131 clone has been found
around the globe [5-7] and its spread between humans has
been facilitated by international travel [37]. ST405 was
identified as another important resistant sequence type among
human isolates that shared similar virulence and antimicrobial
resistance genes with many ST131 isolates.
As many human isolates from the three countries were highly
similar to each other, the widespread human-to-human
transmission of ESBL-producing E. coli is a strong possibility.
Nevertheless the potential threat posed by animals or animal
food products as sources for human ESBL-positive isolates
cannot be ignored [13]. When clonally related CTX-M-
producing E. coli were identified in community settings,
common infection sources such as food or water were often
suspected [38,39]. The dissemination of resistance genes in E.
coli may occur through multiple routes. It is the opinion of
EFSA that “transmission of ESBL genes, plasmids and clones
from poultry to humans is most likely to occur through the food
chain” [40], however the data presented in a recent review
showed that considerable differences in ESBL types between
poultry and humans in Europe exist, leaving the question open
as to what extent livestock has contributed to the spread of
ESBLs in humans [41]. The ESBL genes are often located on
plasmids and are therefore likely to disseminate via horizontal
gene transfer, as described recently for the transmission of a
blaCTX-M-14-carrying plasmid [42]. This study did not seek to
confirm routes of transmission between man and animals or
animals and man, but to investigate whether organisms similar
at the genetic level were present in different animal species
and man, indicating possible epidemiological links. Such links
might be consistent with food-borne transmission from animal
to man, but equally, might indicate exposure of animals to
human faecal bacteria in sewage or flooding incidents or by
other routes.
This work demonstrated that microarray analysis is a useful
tool for detecting the genetic diversity of a large number of
ESBL-producing E. coli isolates although we recognize one
weakness regarding the inability to differentiate group and sub-
groups of ESBL in sufficient depth. The amount of data
generated by this small array platform is more manageable
compared with the whole genome glass slide microarrays
[43,44] or whole genome sequencing. The whole genome
arrays provide more information on genes located on the
chromosome, but less information on virulence genes and
mobile genetic elements, such as plasmids, where the ESBL
and pAmpC-β-lactamase genes are often located. The
associations of some genes with E. coli from certain animal
species also suggest that a targeted approach can provide
useful epidemiological information.
The isolates analysed in this study were highly diverse
especially those from The Netherlands and Germany. The
results do not necessarily reflect the diversity of isolates in that
country and that species in general, because the isolates were
collected from different surveillance programmes and between
2005 and 2009. Some of the observed diversity might therefore
reflect differences in the sampling strategies used and in the
time periods when samples were taken. There is also the need
to be particularly cautious when only very small numbers of
isolates were analysed (e.g. those from Germany) and indeed
a recommendation for future work is the application of agreed
standardised sampling protocols.
The clusters defined by the arrays showed poor congruence
with MLST data, i.e. isolates of different, unrelated STs were
found within the same array cluster, and isolates sharing the
same ST were found in different array clusters; this observation
is consistent with a previous study on ExPEC isolates from
animals, where no correlation between virulence and
antimicrobial resistance genes and genetic backbone of the
host strain was found [45]. This was anticipated given the
mobility and potential transience of many of the genes
represented on the array.
In conclusion, the microarray analysis of ESBL- and AmpC-
producing E. coli isolates showed a high diversity in virulence
and antimicrobial resistance gene contents. The array profiles
of the majority of isolates from humans were generally different
from those isolated from animals, while many human isolates
from the three countries were highly similar in both array
profiles and MLST types. Thus, approaches to minimize
human-to-human transmission are essential for controlling the
spread of ESBL-positive E. coli. From public health
perspective, ESBL-positive E. coli from animals may represent
a reservoir of virulence and resistance genes rather than being
the direct cause of infections in humans.
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